Breakthrough in Single-Cell Sequencing: Scientists Develop Powerful Tool to Uncover Genetic Links to Complex Diseases

Strategic Insights -

A team of scientists at the European Molecular Biology Laboratory (EMBL) has made a significant breakthrough in single-cell sequencing technology, creating a highly sensitive tool that can help uncover links between genetic variants and complex diseases. Known as single-cell DNA-RNA-sequencing (SDR-seq), this innovative approach allows researchers to study both DNA and RNA simultaneously inside the same cell, revolutionizing the field of genome biology.

Key Takeaways:

  • The SDR-seq tool has the potential to transform our understanding of the non-coding regions of the genome, which are responsible for more than 95% of disease-associated variants.
  • The technology can analyze thousands of cells simultaneously, linking genetic changes to gene activity and providing insights into complex diseases such as congenital heart disease, autism, and schizophrenia.
  • The SDR-seq tool can determine variations in the non-coding regions of the genome, allowing researchers to study the parts of DNA where variations linked to disease are most likely to occur.
  • The technology has been tested on B-cell lymphoma cells, showing that increasing variants in a cell is associated with a more malignant B-cell lymphoma state.
  • The SDR-seq tool has the potential to play a significant role in treating a broad range of complex diseases and may first help in developing better screening tools for diagnosis.
  • The technology has been developed through collaborations between researchers at EMBL, Stanford University School of Medicine, and Heidelberg University Hospital.

Statistics:

  • More than 95% of disease-associated variants occur in non-coding regions of the genome.
  • SDR-seq can analyze thousands of cells simultaneously, providing a high-throughput approach to studying genetic variants.
  • The tool has shown that increasing variants in a cell is associated with a more malignant B-cell lymphoma state.
  • The SDR-seq tool has the potential to transform our understanding of complex diseases and may first help in developing better screening tools for diagnosis.

Sources:

  • Dominik Lindenhofer, et al. "Single-Cell DNA-RNA Sequencing" (published in Nature Methods)
  • European Molecular Biology Laboratory (EMBL). "Scientists develop powerful tool to uncover genetic links to complex diseases"
  • Judith Zaugg et al. (EMBL research group)
  • Kyung-Min Noh et al. (EMBL research group)
  • Oliver Stegle (EMBL research group)
  • Wolfgang Huber et al. (EMBL and Universitatsklinikum Heidelberg research groups)
  • Sasha Dietrich et al. (Universitatsklinikum Heidelberg research group)